Minor orthopedic implant market to be worth $2.2 billion by 2021, analysts say

The minor orthopedic replacement implant market will grow from $1.5 billion in 2017 to $2.2 billion in 2021, according to analysts from The Business Research Co.. The company’s  Minor Orthopedic Replacement Implants report said the industry will experience an annual growth rate of over 7%,  driven by a higher rate of arthritis and fractures. Osteoarthritis

Zeiss launches 2D super resolution mode for Airyscan

Zeiss recently announced that it has launched its new 2D super resolution mode that delivers 120 nm lateral resolution for its Airyscan. The new mode is a 32-channel GaAsP array detector that captures more spatial information than other confocal microscopes. The 2D super resolution uses the spatial information to make an optical section of 0.2

China CFDA proposes regulatory framework for 3D-printed medical devices

Stewart Eisenhart, Emergo Group Medical device market regulators at the China Food and Drug Administration (CFDA) have published new guidance proposing registration requirements for devices produced via 3D printing or additive manufacturing. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do

How to redesign medical carts to reflect changing healthcare settings

The way to redesign medical carts for better practicality and maneuverability for changing healthcare settings is making lighter power sources, according to a white paper from Accutronics. “Designs [now focus on innovative solutions to create smaller and lighter carts that are easy to maneuver,” Marty Carlos from the medical device consulting firm Paragon Group said.

FDA’s Breakthrough Device Program: It may make a difference

Dr. Malvina Eydelman, Director of the Division of Ophthalmic, and Ear, Nose, and Throat Devices, Office of Device Evaluation FDA’s Breakthrough Devices Program is beginning to show important results for patients since it was established in late 2016 under the 21st Century Cures Act to help patients gain timely access to breakthrough technologies. Consider Second Sight

8 women medtech innovators you need to know

As we celebrate more women becoming medtech leaders and paving the way for innovation, it’s important to remember the many accomplishments women have already made when it comes to the advancement of health and medicine. X-rays on the battlefield, the American Red Cross, leprosy treatment and more — these advances happened because of women. As

Pages: 1 2 3 4 5 6 7 8 9

Masimo expected to grow through 2025 as it branches out, analyst says

Masimo (Nasdaq: MASI) should enjoy growth through the middle of the next decade, thanks to its exploration of opportunities outside its core market that are more driven by hospital automation, according to a new equity research report out of Barclays. Masimo is on track to having 8–10% top-line growth and 12–15% earnings per share growth through

Medtech stories we missed this week: March 16, 2018

From Intricon expanding its manufacturing space to Arthrex signing a global distribution deal, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Intricon expands medical footprint Intricon announced in a March 13 press release that it has signed a 5-year lease that will secure 30,000 sq. ft of manufacturing

MDSAP certification expanded for Brazilian, South American medical device companies

By Stewart Eisenhart, Emergo Group Brazilian medical device market regulator ANVISA has officially extended applicability of the Medical Device Single Audit Program (MDSAP) to domestic manufacturers as well as other companies based in South America. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s

Mayo Clinic and Orbita forge partnership to expand health and wellness content reach

Mayo Clinic and Orbita recently announced that they have collaborated to deliver Mayo Clinic’s health and wellness content through digital voice assistants — with the goal of improving patient education, engagement and quality of care. Orbita’s digital experience management services include voice and conversational artificial intelligence technologies that work with chatbots, Amazon Alexa, Google Home and more. Mayo Clinic,

Harmonus receives FDA clearance for ProBx software

Harmonus (Boston) announced that it has received FDA 510(k) clearance for its ProBx software for MRI-guided prostate interventions. The software is a solution to a problem of suboptimal prostate cancer diagnoses and provides doctors and patients with better options to diagnose and treat prostate cancer. ProBx software precisely and efficiently targets and confirms suspicious lesions, unlike

Indian CDSCO releases FAQ on medical device rules

By Stewart Eisenhart, Emergo Group The Central Drugs Standard Control Organization (CDSCO), India’s medical device market regulator, has published a new Frequently Asked Questions (FAQ) document to clarify industry questions regarding the country’s new medical device oversight system. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post

Hologic partners with University of Minnesota on athletic performance software

Hologic (Marlborough, Mass.) has signed an exclusive agreement with the University of Minnesota to be the distributor of the university-developed Dexalytics: Teams athletic performance software in North America. The financial terms of the agreement were not disclosed. Hologic’s Horizon dual X-ray absorptiometry (DXA) system already provides precise body composition assessment. What the cloud-based Dexalytics software is

Abzena chooses Sartorius Stedim Biotech as its U.S. equipment supplier

Abzena recently announced that it has chosen Sartorius Stedim Biotech as its preferred U.S. equipment supplier. Under the deal, Abzena’s CDMO facilities in Bristol, Penn. and San Diego will be supplied with Sartorius Stedim Biotech equipment. Sartorius Stedim will supply end-to-end process solutions in single-use format. “We are pleased to have been selected by Abzena,

Zeiss releases machine learning for microscopy

Zeiss recently announced that it has launched its Zeiss Zen Intellesis machine learning capability that allows researchers to perform an advanced analysis of imaging samples across multiple microscopy methods. “Zeiss Zen Intellesis is an important first step in our goal to rapidly bring new solutions to our customers through digitalization. By adding robust new capabilities like